Webinars >>Clinical Trials
5 Steps to Finding the Best Sites for Your Clinical Trial

Clinical trial outcome is directly related to the quality and reliability of the participating clinical sites. A good clinical site not only recruits at an optimum rate but maintains high quality of data, timely completion of records, adequate level of enthusiasm, and high level of regulatory compliance. Robust feasibility analysis by sponsors or CROs goes a long way in defining good experiences once the trial commences. Common practice to select sites based on past experience or presence of a famous PI frequently backfire when poorly selected sites under-perform and drain resources leading to financial loss and delayed time-lines. It is critical for sponsors to create and implement clear and precise matrices for the feasibility analysis of sites before their selection to participate in a given clinical trial.
Why should you attend:
​
This webinar, presented by a leading clinical trial expert, will discuss best practices for clinical site feasibility. Common errors in site selection and potential solutions will be discussed. The seminar will highlight key areas that should be covered in the site feasibility analysis, along with tips for adjustments to fit the desired sites. Best practices for incorporating factors governing selection of sites such as sponsor preferences, site and PI visibility, subject matter expert opinions, past history, publicly available information on past performance, financial and logistical considerations and many other factors will be discussed.  The seminar will highlight key regulatory requirements, dos and don’ts, common areas of concern, and trouble-shooting practices for FDA regulated industry using case studies and examples from the presenter’s vast experience helping companies big and small find good clinical sites. The webinar will provide precise and complete list of measures and components of checklists to be implemented by sponsors to bullet-proof their site selection.
Areas Covered in the Session:
  • Best practices for site selection
  • Similarity and differences in trials for drugs, biologics and medical devices
  • How to best use the subject matter expert opinion for site selection
  • Pros and cons of using “famous” sites in your study
  • Ways to use new and inexperienced sites
  • Risk-based site selection
  • Strategies for findings the best sites for your trials
Who will benefit:
  • Clinical research associates
  • Clinical project managers
  • Sponsors
  • Regulatory affairs personnel
  • Quality assurance personnel
  • Vice presidents, Directors and Managers
  • People interested in investing in the FDA-regulated industry
Date: October 20, 2020
​Duration: ​60 Minutes
​Time: 1 PM EST

Speaker: Mukesh Kumar
​PhD, RAC | Brij Strategic Consultations,  USA​

    For more info, fill the box below. We will contact you within 24 hrs.
For additional information on the workshop agenda and logistics, please call 410-501-5777 or email: info@fdamap.com